COMMUNIQUÉS West-GlobeNewswire

Nabriva Therapeutics to Present Data at ECCMID Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia
13/04/2018
Six abstracts support lefamulin as a potential first-in-class pleuromutilin antibiotic targeting CABP pathogens, including drug resistant phenotypes DUBLIN, Ireland, April 13, 2018 (GLOBE NEWSWIRE) -- Nabriva [...]
Rhizen Pharmaceuticals S.A. receives FDA Fast Track Designation for Tenalisib (RP6530), a highly selective dual PI3K delta/gamma inhibitor for the treatment of patients with relapsed and/or refractory Cutaneous T-cell Lymphoma (CTCL)
13/04/2018
La Chaux-de-Fonds, Switzerland, April 13, 2018 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A., today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for Tenalisib (RP6530 [...]
Shire plc: Form 8 Opening Position Disclosure - Takeda Pharmaceutical Company Limited
13/04/2018
FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Shire plc (b) Owner or controller of interests [...]
Shire plc: Form 8 Opening Position Disclosure - Shire plc
13/04/2018
FORM 8 (OPD) PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Shire plc (b) Owner or controller of interests [...]
MediciNova Announces Presentation of Significant Positive Results from Interim Analysis of the Phase 2 Trial of MN-001 (tipelukast) in NASH / NAFLD at the International Liver Congress 2018 in Paris, France
13/04/2018
LA JOLLA, Calif., April 13, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Aino Health AB (publ): Aino Health AB signs cooperation agreement with Attendo
13/04/2018
Aino Health and Attendo Health Care Services have signed a cooperation agreement regarding Aino's HealthManager platform. With Aino's HealthManager, Attendo extends its portfolio for corporate health management [...]
Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2018
13/04/2018
Company Release no. 09/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 13 April 2018 Veloxis Pharmaceuticals A/S - Passing of Annual General Meeting 2018 Summary: At Veloxis Pharmaceuticals A/S’ Annual General [...]
BIOHIT OYJ’S OWNERSHIP IS EXPANDING
13/04/2018
Biohit Oyj Stock Exchange Release April 13, 2018 at 9:30 am local time (EEST) The company has become aware that Biohit Oyj’s ownership is possibly expanding. With the possible trade of shares, Biohit Oyj’s partner [...]
Shire plc : Rule 2.9 Announcement
13/04/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 13 April 2018 [...]
Kiadis Pharma announces Annual Results for the year ended December 31, 2017
13/04/2018
Kiadis Pharma announces Annual Results for the year ended December 31, 2017 Significantly strengthened cash position; raised over EUR 60 million in equity and debt (gross, including raise in March 2018) Filed Marketing [...]
Immutep Completes A$6.31 Million Share Purchase Plan; Raises Total of A$13.16 Million
13/04/2018
SYDNEY, Australia, April 12, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“ Immutep ” or the “ Company ”) advises that its Share Purchase Plan (“SPP”) closed as planned on 6 April 2018. The [...]
PotNetwork Holdings, Inc. Nationally Syndicated “Mick Bazsuly Show” Feature Presentation Moved to Tuesday, April 17, at 10:00 AM
13/04/2018
Senior Advisor Bruce Barren Set to Discuss OTCQB Uplisting Plans, Q1 2018 Growth Numbers and 2017 Consolidated Audited Financial Returns FT LAUDERDALE, Fla., April 12, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- [...]
Update: Konica Minolta Healthcare, HydroCision Announce Distribution Agreement for TenJet System Used in Minimally Invasive Tendinopathy Treatments
13/04/2018
WAYNE, N.J., April 12, 2018 (GLOBE NEWSWIRE) -- This announcement updates a prior version released April 11, 2018. Konica Minolta Healthcare Americas, Inc., a leader in MSK ultrasound, announced today a distribution [...]
Adamas Announces Multiple Data Presentations at the American Academy of Neurology Annual Meeting
12/04/2018
EMERYVILLE, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced it will make six data presentations at the 70 th Annual Meeting of the American Academy of Neurology ( [...]
HempTech (HTCO) is Now Nuvus Gro (NUVG)
12/04/2018
Ticker Change to NUVG Saint Petersburg, FL, April 12, 2018 (GLOBE NEWSWIRE) -- Nuvus Gro Corp. (OTC PINK: NUVG), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and [...]
Amarin Sponsors Three Scientific Presentations Scheduled for National Lipid Association Scientific Sessions
12/04/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, April 12, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
ICU Medical, Inc. Announces Time of First Quarter 2018 Earnings Conference Call
12/04/2018
SAN CLEMENTE, Calif., April 12, 2018 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI ), a leader in the development, manufacture and sale of innovative medical devices used in infusion therapy and critical care [...]
Conformis to Host First Quarter 2018 Financial Results Conference Call and Webcast on May 2, 2018
12/04/2018
BILLERICA, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS ) announced today that it will host a conference call on Wednesday, May 2, 2018, at 4:30 p.m. Eastern Time to discuss its financial [...]
Galapagos announces ISABELA Phase 3 program in IPF
12/04/2018
Mechelen, Belgium; 12 April 2018, 22.01 CET - Galapagos announces the design of a worldwide Phase 3 program, based on feedback from the FDA and EMA, to evaluate GLPG1690 in patients with idiopathic pulmonary fibrosis. [...]

Pages